Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Clinical Nuclear Medicine
|
December 9, 2025
Clinical Translation of a Dual Integrin-and GRPR-targeting PET Radiotracer 68 Ga-DOTA-RGD-RM26 in Glioma
Rongxi Wang, Ziyang Li, Li'ao Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 9, 2025
[<sup>68</sup>Ga]Ga-P16-093 PET/CT in newly diagnosed prostate cancer: Histopathological validation and comparison with [<sup>68</sup>Ga]Ga-PSMA-11
Jiarou Wang, Linlin Li, Jingci Chen, et al.
Clinical Nuclear Medicine
|
November 5, 2024
Glucagon-Like Peptide-1 Receptor-Targeted PET/CT With 68 Ga-HBED-CC-Exendin-4 in Localizing Insulinoma : A Head-to-Head Comparison to 68 Ga-NOTA-Exendin-4
Linlin Li, Guochang Wang, Jiarou Wang, et al.
Vascular Health and Risk Management
|
April 20, 2026
Taoren Honghua Jian Regulate NLRP3 Inflammasome of Coronary Artery Disease Patients: A Multi-Center, Double-Blind, Randomized Controlled Trial
Min Du, Xiaoteng Feng, Na Zhang, et al.
ACS Pharmacology & Translational Science
|
October 17, 2024
Evaluation of Angiotensin-Converting Enzyme 2 Expression <i>In Vivo</i> with Novel <sup>68</sup>Ga-Labeled Peptides Originated from the Coronavirus Receptor-Binding Domain
Linlin Li, Rongxi Wang, Li He, et al.
Clinical Nuclear Medicine
|
February 24, 2025
Clinical Application of 68 Ga-Pentixafor PET/CT for the Detection of Thymoma: A Pilot Study
Rongxi Wang, Xuehan Gao, Xingtong Peng, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 24, 2024
Comparison of novel PSMA-targeting [<sup>177</sup>Lu]Lu-P17-087 with its albumin binding derivative [<sup>177</sup>Lu]Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a first-in-human study
Linlin Li, Jiarou Wang, Guochang Wang, et al.
Clinical Nuclear Medicine
|
January 14, 2025
Gastrin-Releasing Peptide Receptor Targeting PET/CT With 68 Ga-NOTA-RM26 in the Assessment of Glioma and Combined Multiregional Biopsies
Rongxi Wang, Yilin Li, Ziyang Li, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 20, 2025
Dansylated Amino Acid-Modified Long-Acting PSMA Derivatives <sup>68</sup>Ga/<sup>177</sup>Lu-LNC1011 as Prostate Cancer Theranostics
Hongzhang Yang, Jiarou Wang, Xuejun Wen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 14, 2025
Deep learning-based non-invasive prediction of PD-L1 status and immunotherapy survival stratification in esophageal cancer using [<sup>18</sup>F]FDG PET/CT
Fei Xie, Mobei Zhang, Chunhong Zheng, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Clinical Nuclear Medicine
|
December 9, 2025
Clinical Translation of a Dual Integrin-and GRPR-targeting PET Radiotracer 68 Ga-DOTA-RGD-RM26 in Glioma
Rongxi Wang, Ziyang Li, Li'ao Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 9, 2025
[<sup>68</sup>Ga]Ga-P16-093 PET/CT in newly diagnosed prostate cancer: Histopathological validation and comparison with [<sup>68</sup>Ga]Ga-PSMA-11
Jiarou Wang, Linlin Li, Jingci Chen, et al.
Clinical Nuclear Medicine
|
November 5, 2024
Glucagon-Like Peptide-1 Receptor-Targeted PET/CT With 68 Ga-HBED-CC-Exendin-4 in Localizing Insulinoma : A Head-to-Head Comparison to 68 Ga-NOTA-Exendin-4
Linlin Li, Guochang Wang, Jiarou Wang, et al.
Vascular Health and Risk Management
|
April 20, 2026
Taoren Honghua Jian Regulate NLRP3 Inflammasome of Coronary Artery Disease Patients: A Multi-Center, Double-Blind, Randomized Controlled Trial
Min Du, Xiaoteng Feng, Na Zhang, et al.
ACS Pharmacology & Translational Science
|
October 17, 2024
Evaluation of Angiotensin-Converting Enzyme 2 Expression <i>In Vivo</i> with Novel <sup>68</sup>Ga-Labeled Peptides Originated from the Coronavirus Receptor-Binding Domain
Linlin Li, Rongxi Wang, Li He, et al.
Clinical Nuclear Medicine
|
February 24, 2025
Clinical Application of 68 Ga-Pentixafor PET/CT for the Detection of Thymoma: A Pilot Study
Rongxi Wang, Xuehan Gao, Xingtong Peng, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 24, 2024
Comparison of novel PSMA-targeting [<sup>177</sup>Lu]Lu-P17-087 with its albumin binding derivative [<sup>177</sup>Lu]Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a first-in-human study
Linlin Li, Jiarou Wang, Guochang Wang, et al.
Clinical Nuclear Medicine
|
January 14, 2025
Gastrin-Releasing Peptide Receptor Targeting PET/CT With 68 Ga-NOTA-RM26 in the Assessment of Glioma and Combined Multiregional Biopsies
Rongxi Wang, Yilin Li, Ziyang Li, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 20, 2025
Dansylated Amino Acid-Modified Long-Acting PSMA Derivatives <sup>68</sup>Ga/<sup>177</sup>Lu-LNC1011 as Prostate Cancer Theranostics
Hongzhang Yang, Jiarou Wang, Xuejun Wen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 14, 2025
Deep learning-based non-invasive prediction of PD-L1 status and immunotherapy survival stratification in esophageal cancer using [<sup>18</sup>F]FDG PET/CT
Fei Xie, Mobei Zhang, Chunhong Zheng, et al.
Page
of 4